Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Metrics to compare | STVN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTVNPeersSector | |
---|---|---|---|---|
P/E Ratio | 48.4x | 25.6x | −0.6x | |
PEG Ratio | −2.02 | −0.65 | 0.00 | |
Price/Book | 4.2x | 4.3x | 2.6x | |
Price / LTM Sales | 5.1x | 4.0x | 3.2x | |
Upside (Analyst Target) | 19.4% | 0.0% | 44.1% | |
Fair Value Upside | Unlock | 4.0% | 6.2% | Unlock |